openPR Logo
Press release

$3.0 Bn, Pneumonia Testing Market (by 2030) Growth Forecast at 6.5% CAGR - Exclusive Report by Allied Market Research

05-24-2023 01:15 PM CET | Health & Medicine

Press release from: Allied Market Research

Pneumonia Testing Market

Pneumonia Testing Market

๐“๐ก๐ž ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ $1.6 ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2020 ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ $3.0 ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ 2030, ๐ฐ๐ข๐ญ๐ก ๐š ๐œ๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐š๐ง๐ง๐ฎ๐š๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐š๐ญ๐ž (๐‚๐€๐†๐‘) ๐จ๐Ÿ 6.5% ๐Ÿ๐ซ๐จ๐ฆ 2021 ๐ญ๐จ 2030.Pneumonia is a serious respiratory illness that can lead to severe complications, particularly in individuals with weakened immune systems, such as young children, the elderly, and individuals with chronic medical conditions. Accurate and timely diagnosis is crucial for effective treatment and management of pneumonia. That's why the development and availability of various diagnostic tests for pneumonia play an important role in the healthcare industry.

The COVID-19 pandemic has had a positive impact on the pneumonia testing market. With a high number of COVID-19 cases worldwide, many individuals who contract the virus are also developing pneumonia, leading to a higher demand for diagnostic tests. Furthermore, the increased focus on research and development for the treatment of COVID-19-associated pneumonia is also driving growth in the market. As a result, the pneumonia testing market is expected to experience significant growth in the coming years.

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ :
Abott Laboratories, F.hoffman La roche, Thermofischer Inc, Hologic Inc, Biomerieux SA, Quidel Corporation, Bio Rad laborateries, Beckton and Dickinson Company, AdvanDx, Beckman Coulter

๐†๐ž๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐จ๐Ÿ ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ@https://www.alliedmarketresearch.com/request-sample/3776

The growth of the Pneumonia Testing Market is driven by various factors such as the increasing adoption of point-of-care testing, advancements in nucleic acid detection, growth in the geriatric population, and a rise in the prevalence of pneumonia among children globally. The increase in healthcare expenditure and the presence of advanced healthcare infrastructure, along with the availability of reimbursements and key market players, present significant growth opportunities for the market. However, the use of traditional methods such as cultures for detecting pneumonia causative organisms may slow down the market growth to some extent, as these methods are time-consuming and have a higher error rate.

โ€ƒ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ

The Pneumonia Testing Market can be segmented into two types:

Consumables: This segment includes reagents, kits, and other materials used in the testing process.

Analyzers: This segment includes equipment and instruments used for analyzing test samples in the detection of pneumonia. These instruments include point-of-care devices and laboratory-based analyzers.

๐“๐ก๐ž ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐œ๐š๐ง ๐›๐ž ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐›๐ฒ ๐ฆ๐ž๐ญ๐ก๐จ๐ ๐ข๐ง๐ญ๐จ ๐ญ๐ก๐ซ๐ž๐ž ๐œ๐š๐ญ๐ž๐ ๐จ๐ซ๐ข๐ž๐ฌ:

Molecular Diagnostics: This method involves the detection of genetic material (DNA or RNA) of the pathogen causing pneumonia.

Point of Care Testing (POCT): This method involves the use of rapid diagnostic tests that can be performed at the patient's bedside or in a primary care setting.

Immunodiagnostics: This method involves the detection of antibodies produced by the body in response to an infection, including pneumonia. It includes tests such as Enzyme-Linked Immunosorbent Assays (ELISAs) and Rapid Antigen Detection Tests (RADTs).

๐Œ๐š๐ค๐ž ๐š๐ง ๐„๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐›๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ฒ๐ข๐ง๐ @https://www.alliedmarketresearch.com/purchase-enquiry/3776

๐“๐ก๐ž ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐œ๐š๐ง ๐›๐ž ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐›๐ฒ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐ข๐ง๐ญ๐จ ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐œ๐š๐ญ๐ž๐ ๐จ๐ซ๐ข๐ž๐ฌ:

Enzyme-Linked Immunosorbent Assay (ELISA): This is a widely used immunodiagnostic method for detecting the presence of specific antibodies in the blood.

Immunofluorescence: This technology uses fluorescence-labeled antibodies to detect the presence of specific antigens in a sample.

Western Blot: This technology is used to detect specific proteins in a sample and to identify their molecular weight.

Polymerase Chain Reaction (PCR): This technology is used to amplify specific DNA sequences, enabling the detection of low levels of the pathogen causing pneumonia.

Immunohistochemistry (IHC): This technology uses antibodies to detect the presence of specific antigens in tissue samples.

Others: This category includes other technologies used in pneumonia testing such as Rapid Antigen Detection Tests (RADTs), Microbial Culture, and Nucleic Acid Hybridization.

๐“๐ก๐ž ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐œ๐š๐ง ๐›๐ž ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐›๐ฒ ๐ž๐ง๐-๐ฎ๐ฌ๐ž๐ซ ๐ข๐ง๐ญ๐จ ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐œ๐š๐ญ๐ž๐ ๐จ๐ซ๐ข๐ž๐ฌ:

Hospitals: This segment includes both inpatient and outpatient facilities that offer pneumonia testing services.

Diagnostic Laboratories: This segment includes independent and hospital-affiliated diagnostic labs that offer pneumonia testing services.

Homecare: This segment includes individuals who perform pneumonia tests at home using Point of Care (POC) testing devices.

Others: This segment includes other end-users such as nursing homes, clinics, and long-term care facilities.

๐“๐ก๐ž ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐œ๐š๐ง ๐›๐ž ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ž๐ ๐›๐ฒ ๐ซ๐ž๐ ๐ข๐จ๐ง ๐ข๐ง๐ญ๐จ ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐œ๐š๐ญ๐ž๐ ๐จ๐ซ๐ข๐ž๐ฌ:

North America: This region includes the United States, Canada, and Mexico.
Europe: This region includes countries such as Germany, France, the United Kingdom, Italy, Spain, and the rest of Europe.
Asia-Pacific: This region includes countries such as Japan, China, Australia, India, South Korea, and the rest of the Asia-Pacific region.
LAMEA: This region includes countries such as Brazil, Saudi Arabia, South Africa, and the rest of the Latin America, Middle East, and Africa region.

Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America has the highest Pneumonia Testing Market Share in 2020, owing to a rise in prevalence of chronic diseases, growth in healthcare expenditure, the surge in presence of advanced healthcare infrastructure, increase in the availability of reimbursements, and rise in presence of major market players in the region are the major factors driving the growth of the pneumonia testing market in North America.

๐๐ฎ๐ข๐œ๐ค๐ฅ๐ฒ ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐๐ง๐ž๐ฎ๐ฆ๐จ๐ง๐ข๐š ๐“๐ž๐ฌ๐ญ๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ
๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ@https://www.alliedmarketresearch.com/checkout-final/53f88224ae630f1431faa985b7875531

Contact:
David Correa
5933 NE Wi
Toll-Free: 1-800-792-5285
UK: +44-845-528-1300n Sivers Drive
#205,โ€ฏPortland, ORโ€ฏ97220
United States
Hong Kong: +852-301-84916
Indiaโ€ฏ(Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web:โ€ฏhttps://www.alliedmarketresearch.com
Follow Us on:โ€ฏLinkedInโ€ฏTwitter

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies. This helps us dig out market data that helps us generate accurate research data tables and confirm utmost accuracy in our market forecasting. Every data company in the domain is concerned. Our secondary data procurement methodology includes deep presented in the reports published by us is extracted through primary interviews with top officials from leading online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release $3.0 Bn, Pneumonia Testing Market (by 2030) Growth Forecast at 6.5% CAGR - Exclusive Report by Allied Market Research here

News-ID: 3065294 • Views: โ€ฆ

More Releases from Allied Market Research

Horse Betting Market's CAGR Surge: A USD Billion Dollar Growth Story 2022 - 2032
Horse Betting Market's CAGR Surge: A USD Billion Dollar Growth Story 2022 - 2032
Horse betting, one of the oldest forms of bet, has evolved dramatically over the centuries. From its origins in ancient civilizations to the high-tech, data-driven industry it is today, the horse betting market has adapted to cultural, technological, and economic shifts. This article explores the current landscape of the horse betting market, its challenges, opportunities, and the factors driving its growth. The horse betting market was valued at $44.3 billion inโ€ฆ
Password Management Market Growing at a 20.7% CAGR Reach USD 15.2 Billion by 2032
Password Management Market Growing at a 20.7% CAGR Reach USD 15.2 Billion by 203 โ€ฆ
Allied Market Research published a new report, titled, " Password Management Market Growing at a 20.7% CAGR Reach USD 15.2 Billion by 2032 ." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry andโ€ฆ
Cloud Artificial Intelligence Market Growing at 35.8% CAGR Reach USD 887 Billion by 2032
Cloud Artificial Intelligence Market Growing at 35.8% CAGR Reach USD 887 Billion โ€ฆ
Allied Market Research published a new report, titled, "Cloud Artificial Intelligence Market Growing at 35.8% CAGR Reach USD 887 Billion by 2032." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determineโ€ฆ
Microserver Market Growing at 15.8% CAGR Reach USD 122.4 Billion by 2032
Microserver Market Growing at 15.8% CAGR Reach USD 122.4 Billion by 2032
Allied Market Research published a new report, titled, "Microserver Market Growing at 15.8% CAGR Reach USD 122.4 Billion by 2032." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine steps toโ€ฆ

All 5 Releases


More Releases for Pneumonia

Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve โ€ฆ
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903 With the rise of antibiotic resistance, aging populations, and increased use of ventilators inโ€ฆ
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776 Key Market Drivers โ€ข Riseโ€ฆ
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To โ€ฆ
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market? The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies likeโ€ฆ
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and currentโ€ฆ
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lungโ€™s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills. Read Report Overview -โ€ฆ
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview: The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH.  Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market.  Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For aโ€ฆ